penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Pavan Atluri, M.D.
Cardiovascular Surgery

 
  • Profile Home
  • Appointments
  • Education
  • Memberships
  • Research
  • Publications

Administrative Office:
Penn Presbyterian Medical Center
Heart & Vascular Pavilion, Suite 2A
51 North 39th Street
Philadelphia, PA 19104
Administrative Assistant: Donna McLaughlin
Administrative Telephone: 215-662-9595
Administrative Fax: 215-243-3243

Hospital of the University of Pennsylvania
3400 Spruce Street
6 Silverstein Pavilion
Philadelphia, Pennsylvania 19104
Administrative Telephone: 215-662-9595
Administrative Fax: 215-243-3243

Clinical Office:
Penn Presbyterian Medical Center
Heart & Vascular Pavilion, Suite 2A
51 North 39th Street
Philadelphia, PA 19104
Clinical Telephone: 215-662-9595
Clinical Fax:
215-243-3243

Perelman Center for Advanced Medicine
Penn Heart and Vascular Center
East Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
Clinical Telephone: 215-662-9595
Clinical Fax:
215-243-3243

Contact Information (internal use only)

pavan.atluri@uphs.upenn.edu

 

Dr. Pavan Atluri completed his general surgery and cardiothoracic surgery training at the University of Pennsylvania. He remains on faculty in the division of cardiovascular surgery. Dr. Atluri’s clinical interests are focused on minimally invasive cardiovascular and valvular surgery, mechanical circulatory support, cardiac transplantation and conventional and molecular myocardial revascularization. His research interests are in the areas of minimally invasive cardiac surgery, myocardial neovascularization, myocardial regeneration, and management of heart failure. Dr. Atluri has a translational research lab focused on tissue engineering, progenitor cell mediated myocardial vasculogenesis and myocardial regeneration.

 
Appointments
 
Hospital and Administrative Appointments
2011 - present Assistant Professor of Surgery
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
2011 - present Assistant Professor of Surgery
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
 
2011 - present Assistant Professor of Surgery
Pennsylvania Hospital
Philadelphia, Pennsylvania
 
2011 - present Surgical Director, Mechanical Circulatory Support
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
 
Other Appointments
2001 - 2007 Assistant Instructor of Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
01/06 Children of the Americas (COTA) Medical/Surgical Mission to Guatemala
 
2007 - present Instructor of Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
   
2012 - present Committee on Minimally Invasive Valvular Surgery, Society for Heart Valve Disease
   
2011 - 2013 Council on Cardiovascular Surgery and Anesthesia Membership and Communications Council, American Heart Association
   
2012 - present Grant Reviewer, American Heart Association, Surgery Subsection
 
Education/Training
1994 - 1998 B.S.
Biology-Sociology, Summa cum Laude
Union College
Schenectady, New York
 
1997 - 2001 M.D.D.R.
Doctor of Medicine with Distinction in Research
Albany Medical College
Albany, New York
 
Postgraduate Training and Fellowship Appointments
2001 - 2002 Internship in General Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2002 - 2008 Residency in General Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2004 - 2006 Post-Doctoral Research Fellow
Harrison Department of Surgical Research
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2007 - 2008 Chief Resident in General Surgery
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2008 - 2010 Resident in Cardiothoracic Surgery (Cardiac Track)
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 
2010 -2011 Fellow, Cardiovascular Surgery - Heart-Failure, Transplantation,
and Mechanical Circulatory Support; Minimally Invasive Cardiac Surgery
Division of Cardiovascular Surgery
Department of Surgery, University of Pennsylvania
Philadelphia, Pennsylvania
 
Memberships/Societies
 
National/International Societies
  • Alpha Omega Alpha (AOA)
  • American College of Surgeons (ACS)
  • Fellow (FAHA), American Heart Association (AHA)
  • Council on Cardiovascular Surgery and Anesthesia Association for Academic Surgery (AAS)
  • American Medical Association (AMA)
  • International Society for Heart Research (ISHR)
  • American Section International Society for Heart and Lung Transplantation (ISHLT)
  • National Eagle Scout Association
  • Phi Beta Kappa
  • The Society of Thoracic Surgeons (STS)    
 
Research

Pavan Atluri has a translational molecular research laboratory that is studying novel strategies for myocardial tissue engineering and endogenous endothelial progenitor cell mediated neovascularization of ischemic myocardium. Further research work is being conducted in the areas of myocardial regeneration and myocardial protection for compromised myocardial tissue. During his residency, Dr. Atluri dedicated two focused years in an independently NIH funded post-doctoral research fellowship in the laboratory of Dr. Y.Joseph Woo.

Additionally, Pavan works on clinical projects evaluating optimization of minimally invasive mitral valve surgery, mechanical circulatory support, myocardial revascularization, and orthotopic heart tranplantation.

 
Publications
 
Research Publications, Peer Reviewed
  1. Atluri P, Fleck MW, Shen Q, Mah SJ, Stadfelt D, Barnes W, Goderie S, Temple S, and Schneider AS. Functional nicotinic acetylcholine receptor expression in stem and progenitor cells of the early embryonic mouse cerebral cortex. Developmental Biology 2001; 240: 143-156.
  2. Schneider AS, Atluri P, Shen Q, Barnes W, Mah SJ, Stadfelt D, Goderie SK, Temple S, and  Fleck MW. Functional nicotinic acetylcholine receptor expression on stem and progenitor cells of the early embryonic nervous system. Ann. N.Y. Acad. Sci. 2002;971: 135-138.
  3. Woo YJ, Atluri P, Grand TJ, Hsu V, Gardner TJ. Should protamine dosing formulas be recalculated for off-pump coronary artery bypass grafting?  Heart Surg Forum. 2003; 7: 42-44.
  4. Atluri P, Raper S. Factor V leiden and post-operative deep vein thrombosis in patients undergoing open roux-en-y gastric bypass surgery. Obes Surg. 2005; 15:561-564.
  5. Woo YJ, Atluri P, Grand TJ, Hsu V, Cheung A. Active thermoregulation improves off-pump coronary artery bypass grafting outcomes.  Asian Cardiovasc Thor Ann 2005; 13:157-160.
  6. Woo YJ, Grand T, Berry MF, Atluri P, Moise A, Hsu V, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL. Stromal-cell derived factor and granulocyte monocyte-colony stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. J Thor Cardiovasc Surg. 2005; 130: 321-329.
  7. Woo YJ, Grand TJ, Zentko S, Cohen JE, Hsu V, Atluri P, Berry MF, Taylor MD, Moise MA, Burdick J, Fisher O, Kolakowski S.  Creatine phosphate administration preserves myocardial function in a model of off-pump coronary revascularization.  J Cardiovasc Surg. 2005; 46:297-303.
  8. Atluri P, Liao GP, Panlilio CM, Hsu VM, Leskowitz MJ, Morine KJ, Cohen JE, Berry MF, Suarez EE, Murphy DA, Lee WMF, Gardner TJ, Sweeney HL, Woo YJ. Neovasculogenic therapy with granulocyte-monocyte colony stimulating factor and stromal cell derived factor-1α augments perfusion, reverses ischemia and preserves cardiomyocyte viability in ischemic cardiomyopathy. Ann Thor Surg. 2006; 81: 1728-1736.
  9. Cohen JE, Atluri P, Taylor MD, Grand TJ, Liao GP, Panlilio CM, Suarez EE, Zentko SE, Hsu VM, Berry MF, Smith MJ, Gardner TJ, Sweeney HL, Woo YJ. Fructose 1,6-diphosphate Administration Attenuates Post-Ischemic Ventricular Dysfunction. J Heart Lung Circ. 2006; 2: 119-123.
  10. Kolakowski S, Berry MF, Grand TJ, Fisher O, Moise MA, Cohen JE, Hsu V, Atluri P, Woo YJ. Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy. J Card Surg. 2006; 21: 559-564.
  11. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Hsu VM, Cohen JE, Chaudhry HW.  Therapeutic Delivery of Cyclin A2 Induces Myocardial Regeneration and Enhances Cardiac Function in Ischemic Heart Failure. Circulation. 2006; 114(1 Suppl): I206-13.  
  12. Atluri P, Neligan PJ, Acker MA, Bensall DL, Horak J. Prone Positioning to Treat Acute Severe Pulmonary Edema in the Post-Cardiac Surgical Patient. Heart Surg Forum. 2006; 9: 762-4.
  13. Hsu VM, Atluri P, Keane M, Woo YJ. Minimally invasive aortic valve papillary fibroelastoma resection. Interactive Cardio Thor Surg. 2006; 5: 779-781.
  14. Woo YJ, Rodriguez E, Atluri P, Chitwood WR. Minimally-invasive, robotic, and off-pump mitral valve surgery. Seminars Thor Cardiovasc Surg 2006; 18: 139-47.
  15. Atluri P, Morine KJ, Liao G, Panlilio CM, Berry MF, Hsu VM, Cohen J, Smith M, Suarez E, Sweeney HL, Woo YJ. Ischemic heart failure enhances endogenous myocardial apelin ligand and apj receptor expression. Cell & Mol Bio Lett 2007; 12:127-138.
  16. Atluri P, Woo YJ. High risk ascending aortic aneurysm repair resulting from giant cell aortitis. Asian Cardiovasc Thor Ann 2007; 15: 252-254.
  17. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Suarez EE, Atluri P, Chaudhry HW.  Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin a2. J Thor Cardiovasc Surg 2007; 133; 4:927-933.
  18. Atluri P, Panlilio CM, Liao GP, Suarez EE, McCormick RC, Hiesinger W, Cohen JE, Smith MJ, Patel AB, Feng W, Woo YJ. Transmyocardial revascularization enhances myocardial vasculogenesis and hemodynamic function. J Thor Cardiovasc Surg 2008; 135; 2:283-291.
  19. Atluri P, Hiesinger W, Gorman RC, Pochettino A, Jessup M, Acker MA, Morris RJ, Woo YJ. Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure. J Cardiothor Surg 2008; 3:26-30.
  20. Atluri P, Woo YJ. Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential. BioDrugs 2008; 22: 209-222.
  21. Atluri P, Kozin ED, Hiesinger W, Woo YJ. Off-pump, minimally invasive, and robotic coronary revascularization yield improved outcomes over traditional on-pump CABG. Int J Med Robot 2009; 5: 1-12.
  22. Augostides JGT, Atluri P. Progress in mitral valve disease: understanding the revolution. J Cardiovasc Anesth 2009; 23: 916-923.
  23. Atluri P, Panlilio CM, Liao GP, Hiesinger W, Harris DA, McCormick RC, Cohen JE, Jin T, Feng W, Levit RD, Dong N, Woo YJ. Acute myocardial rescue with endogenous endothelial progenitor cell therapy. Heart, Lung, Circulation 2010; 11; 644-654.
  24. Woo YJ, Atluri P. “Angiogenesis and surgical or endovascular enhancement of non-coronary collateral circulation:  a new research field”. J Thor Cardiovasc Surg. 2010; 139:1676-1677.
  25. Atluri P. “Myocardial transfection of adeno-hypoxia inducible factor-1α, a novel strategy to potentiate vasculogenesis in ischemic myocardium”. Circ J. 2010; 74:846-847.
  26. Frederick JR, Fitzpatrick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, Marotta N, Smith MJ, Cohen JE, Hiesinger W, Atluri P, Woo YJ. Stromal cell-derived factor-1α activation of tissue engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation 2010; 122; S107-117.
  27. Hiesinger W, Frederick JR, Atluri P, McCormick RC, Marotta N, Muenzer JR, Woo YJ. Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction. J Thor Cardiovasc Surg 2010; 140; 1174-1180.
  28. Atluri P, Acker MA. Pulsatile LVADs: What is the role in the modern era? Semin Thor Cardiovasc Surg 2010; 22; 106-108.
  29. Atluri P, Woo YJ. Minimally invasive, robotic mitral valve surgery: equivalent technical outcomes with improved morbidity. Expert Rev Medical Devices 2011; 8; 115-120.
  30. Atluri P. “Careful echocardiographic analysis of right ventricular function as a long-term prognostic variable in systolic heart failure”. Circ J. 2011; 75: 2054-2055.
  31. Hiesinger W, Vinogradov S, Atluri P, Fitzpatrick JR, Frederick J, Levit R, McCormick R, Muenzer J, Yang E, Marotta N, MacArthur J, Wilson D, Woo YJ. Oxygen-dependent quenching of phosphorescence used to characterize improved myocardial oxygenation resulting from targeted endothelial progenitor cell therapy. J Appl Physio.2011 May;110(5):1460-1465
  32. Atluri P, Acker MA, Jessup ML. The next decade in mechanical assist - advances that will help the patient and the doctor. Current Opin Cardiol 2011; 26:256-260.
  33. Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta N, Frederick JR, Fitzpatrick JR, McCormick RC, Muenzer JR, Levit RD, Yuan LJ, MacArthur JW, Saven JG, Woo YJ. Computational protein design to re-engineer stromal cell-derived factor-1α (SDF) generates a supra-efficient angiogenic polypeptide analog. Circulation 2011; 124:S18-26.
  34. Atluri P, MacArthur JW. A novel strategy to improve end organ function with pulsatile cardiopulmonary bypass. Circ J. 2012; 76: 1087-1088.
  35. Hiesinger W, Brukman MJ, McCormick RC, Fitzpatrick JR, Frederick JR, Yang EC, Muenzer JR, Marotta NA, Berry MF, Atluri P, Woo YJ. Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor-1α angiogenic therapy for acute myocardial infarction in a murine model. J Thoracic and Cardiovasc Surg. 2012; 143:962-966.
  36. Atluri P, Acker MA. Diastolic ventricular support with cardiac support devices: an alternative approach to prevent adverse ventricular remodeling. Heart Failure Rev. 2012. 
  37. Atluri P, Acker MA. Mitral valve surgery for dilated cardiomyopathy - current status and future role. Sem Thor Cardiovasc Surg Semin Thorac Cardiovasc Surg. 2012 Spring; 24:51-8.
  38. Atluri P, Dymond DJ, Woo YJ. Continuous flow left ventricular assist device implantation in the presence of a hostile ventricle. J Thor Cardiovasc Surg – In press.
  39. Atluri P, Ullery BW, MacArthur JW, Goldstone AB, Fairman AS, Hiesinger W, Acker MA, Woo YJ. Rapid onset of fulminant myocarditis portends a favorable prognosis and ability to bridge mechanical support to recovery. Eur J Cardiothor Surg – In Press.
  40. Atluri P, Fairman AS, MacArthur JW, Howard JL, Yang E, Shudo Y, Hiesinger W, Acker MA, Woo YJ. Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility and tricuspid valve competence. J Heart Lung Transp – In Submission.
  41. Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, O’Hara ML, Cohen JE,  Howard JL, Zalewski CM, Acker MA, Rame JE, Woo YJ. Quantitative pre-operative risk assessment of right ventricular failure during destination continuous flow left ventricular assist device implantation. J Heart Lung Transp – In Submission.
  42. Cohen JE, Suarez EE, Smith MJ, Atluri P, Liao GP,  Panlilio CM, Hiesinger W,  Levit RD, McCormick R, Woo YJ. Cripto stimulates myocardial proliferation and enhances ventricular function in ischemic cardiomyopathy.  Ann Thor Surg – In Submission.
  43. Goldstone  AB, Atluri P, Szeto WY, Trubelja A, Howard JL, MacArthur JW, Gorman RC,  Gorman JH, Pochettino A, Bavaria JE, Acker MA, Hargrove WC, Woo YJ. Propensity score adjusted comparison of minimally invasive versus sternotomy approaches to isolated mitral valve repair. J Thor Cardiovasc Surg – In Submission.
Abstracts
  1. Schneider AS, Shen Q, Barnes W, Atluri P, Mah SJ, Temple S, Fleck MW.  Acquisition of functional nicotinic acetylcholine receptors during embryonic development of the mouse cerebral cortex. Society of Neurosciences Abst. 25, #408.15, November 1999.
  2. Atluri P, Shen Q, Barnes W, Mah SJ, Stadfelt D, Fleck MW, Schneider AS. Functional nicotinic acetylcholine receptor expression during early embryonic development of the mouse cerebral cortex. Arthur M. Sackler Colloquia of the National Academy of Sciences Abst. 1, #3, May 2001
  3. Atluri P, Grand T, Berry M, Moise MA, Hsu V, Liao G, Cohen J, Fisher O, Taylor M,  Zentko S, Jayasankar V, Kolakowski S, Woo YJ. Endothelial progenitor cell mediated neovasculogenesis for the treatment of ischemic cardiomyopathy. 42th Annual Meeting of the Pennsylvania Association for Thoracic Surgery, October 9, 2004.
  4. Atluri P, Morine KJ, Liao G, Panlilio C, Berry MF, Hsu V, Cohen J, Smith M, Suarez E, Sweeney HL, Woo YJ. Ischemic heart failure increases local concentrations of the endogenous inotrope apelin-13 and the apj receptor. 27th Annual International Society of Heart Research, American Section Meeting, May 12, 2005, JMCC 2005;38:850.
  5. Moise MA, Berry MF, Atluri P, Barton-Davis E, Fairman R, Sweeney HL, Woo, YJ. Endothelial progenitor cell recruitment as a vasculogenic therapy for rat peripheral ischemia. society for vascular surgery 2005 research initiatives conference. April 7, 2005.
  6. Atluri P, Berry MF, Morine KJ, Liao GP, Panlilio CM, Hsu V, Cohen JE, Smith MJ, Suarez EE, Zentko SE, Leskowitz MJ, Gardner TJ, Sweeney HL, Woo YJ. Endogenous and exogenous apelin mediated inotropic activity enhances cardiac function in heart failure. 43th Annual Meeting of the Pennsylvania Association for Thoracic Surgery, September 29, 2005.
  7. Atluri P, Liao G, Panlilio C, Morine KJ, Berry MF, Hsu V, Cohen J, Smith M, Suarez E, Sweeney HL, Woo YJ. Treatment with granulocyte monocyte colony stimulating factor and stromal cell derived factor 1alpha enhances myocardial perfusion and viability in ischemic cardiomyopathy. American College of Surgeons, 91st Annual Clinical Congress Meeting, October 17, 2005. J Am Coll Surgeons 2005;3(Suppl):S44.
  8. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Cohen JE, Chaudhry HW. Therapeutic delivery of cyclin A2 induced myocardial regeneration enhances cardiac function in ischemic heart failure. American Heart Association Scientific Sessions 2005, November 13, 2005.
  9. Atluri P, Liao GP, Panlilio CM, Morine KJ, Berry MF, Cohen JE, Suarez EE, Hsu V, Smith MJ, Gardner TJ, Seeney HL, Woo YJ. Neovasculogenic therapy with granulocyte-monocyte colony stimulating factor and stromal cell derived factor-1α augments perfusion, reverses ischemia and preserves cardiomyocyte viability in ischemic cardiomyopathy. American Heart Association Scientific Sessions 2005, November 13, 2005.
  10. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Cohen JE, Chaudhry HW. Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2. American Association for Thoracic Surgery 86th Annual Meeting, May 2, 2006.
  11. Atluri P, Morine KJ, Liao GP, Panlilio CM, Woo YJ.  Endothelial progenitor cell targeting to ischemic myocardium attenuates hypoxia and enhances cardiomyocyte viability and function.  Heart Failure Society of America, 10th Annual Scientific Meeting. September 10, 2006.
  12. Atluri P, Panlilio CM, Liao GP, Suarez EE, Cohen JE, Hye JB, Dong N, Woo YJ. Acute myocardial rescue with endogenous endothelial progenitor cell therapy. American Heart Association Scientific Sessions 2006, Vivien Thomas Young Investigator Competition, November 12, 2006.
  13. Atluri P, Panlilio CM, Liao GP, Cheng RC, Chaudhry H, Woo YJ.  Therapeutic endogenous myocardial repair and regeneration. GTCbio Modern Drug Discovery & Development Summit, December 5, 2006.
  14. Cohen JE, Suarez EE, Liao GP, Smith MJ, Atluri P, Hye JB, Panlilio CM, Woo YJ. Cripto stimulates myocardial proliferation and enhances ventricular function in ischemic cardiomyopathy. The Society of Thoracic Surgeons, 43rd Annual Meeting, January 29, 2007.
  15. Atluri P, Suarez EE, Liao GP, Panlilio CM, Hye JB, Hiesinger W, Cohen JE, Smith MJ, Woo YJ. Transmyocardial revascularization enhances myocardial vasculogenesis and hemodynamic function, American Association for Thoracic Surgeons, 87th Annual Meeting, C. Walton Lillehei Young Investigators’ Competition, May 7, 2007.
  16. Atluri P, Hiesinger W, Gorman RC, Pochettino A, Acker MA, Morris RJ, Woo YJ. Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure. Western Thoracic Surgical Association, 33rd Annual Meeting, June 30, 2007.
  17. Hiesinger W, Vinogradov SA, Levit RD, Atluri P, Feng W, Tao J, McCormick RC, Patel AB, Smith MJ, Cohen JE, Suarez EE, Wilson DF, Woo YJ.  Targeted endothelial progenitor cell therapy increases myocardial oxygen tissue pressure characterized in vivo using oxygen-dependent quenching of phosphorescence.  Heart Failure Society of America 11th Annual Meeting, September 16, 2007.
  18. Cohen JE, Atluri P, Heisinger W, McCormick R, Laporte C, Smith MJ, Hsu VM, Patel AB, Woo YJ. Cripto stimulates myocardial proliferation and enhances ventricular function in ischemic cardiomyopathy. American Heart Association Scientific Sessions 2008, November 11, 2008.
  19. Atluri P , McCormick RC, Laporte C, Liao GP, Panlilio C, Hiesinger W, Cohen JE, Gerety PA, Frederick JR, Fitzpatrick JR, Jin T, Levit RD, Smith MJ, Woo YJ. Transmyocardial laser revascularization upregulates endogenous vasculogenic signals and limits myocardial scar. International Society for Minimally Invasive Cardiothoracic Surgery 12th Annual Scientific Meeting, June 4, 2009.
  20. Frederick JR, Fitzpatrick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, Smith MJ, Cohen JE, Liu JP, Atluri P, Woo YJ. Tissue engineered endothelial progenitor cell construct promotes neovasculogenesis, enhances perfusion, and improves ventricular function after myocardial infarction. American College of Surgeons, 95st Annual Clinical Congress Meeting, October 13, 2009.
  21. Frederick JR, Fitzpatrick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, Murthy A, Hsiao PF, Prystowsky AD, Smith MJ, Cohen JE, Atluri P, Woo YJ. Stromal cell-derived factor-1α activation of tissue engineered endothelial progenitor stem cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. American Heart Association Scientific Sesions 2009. November 15, 2009.
  22. Atluri P, Howard JL, Kozin ED, Ullery BW, Hiesinger W, Fitzpatrick JR, Jessup M, Acker MA, Morris RJ, Woo YJ. Ventricular assist devices rescue patients in cardiogenic shock without adversely impacting the complexity of subsequent heart transplantation. International Society For Heart and Lung Transplantation 30th Annual Meeting and Scientific Sessions. April 21, 2010.
  23. Hiesinger W, Frederick JR, Fitzpatrick JR, Atluri P, Levit RD, McCormick RC, Marotta NA, Muenzer JR, Kim AY, Woo YJ. Spliced sdf-1 analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner following myocardial infarction. Western Thoracic Surgical Association 36th Annual Meeting. June 23, 2010.
  24. Atluri P, Ullery BW, Howard JL, Hiesinger W, Fitzpatrick JR, Jessup M, Acker MA, Morris RJ, Woo YJ. Rapid onset of fulminant myocarditis portends a favorable prognosis and ability to bridge mechanical support to recovery.  Heart Failure Society of America, 14th Annual Scientific Meeting. September 12, 2010.
  25. Jassar AS, Sims CA, Atluri P, Hari DM, Bavaria JE, Desai ND. Successful outcome after left ventricle laceration, myocardial infarction, and ventricular septal defect caused by penetrating trauma to the heart. Pennsylvania Association for Thoracic Surgery 48th Annual Meeting. October 8, 2010.
  26. Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta N, Frederick JR, Fitzpatrick JR, McCormick RC, Muenzer JR, Levit RD, Yuan LJ, MacArthur JW, Saven JG, Woo YJ. Computational protein design to re-engineer stromal cell-derived factor-1α (SDF) generates a supra-efficient angiogenic polypeptide analog. Nat Medicine. American Heart Association Scientific Sesions 2010. November 14, 2010.
  27. Atluri P,  Ullery BW, MacArthur JW, Kozin ED, Hiesinger W, Donnelly J, Acker MA, Rame JE, Woo YJ. Continuous flow ventricular assist devices improve functional tricuspid regurgitation and right ventricular function. International Society For Heart and Lung Transplantation 31st Annual Meeting and Scientific Sessions. April 14, 2011.
  28. Donnelly JP, Woo YJ, Morris RJ, Goldberg LR, Wald JW, Atluri P, O'Hara ML, Breuer KA, Marble JF, Avrahami NY, Arabia FA, Rogers JG, Acker MA, Rame JE.  Does the “obesity paradox” in chronic heart failure fade after mechanical circulatory support with continuous flow devices: analysis from the Interagency Registry for Mechanically Assisted Circulatory Support. International Society For Heart and Lung Transplantation 31st Annual Meeting and Scientific Sessions. April 14, 2011.
  29. Hiesinger W, Brukman MJ, McCormick RC, Fitzpatrick JR, Frederick JR, Yang EC, Muenzer JR, Marotta NA, Berry MF, Atluri P, Woo YJ. Myocardial tissue elastic properties determined by atomic force microscopy following sdf-1α angiogenic therapy for acute myocardial infarction. Western Thoracic Surgical Association 37th Annual Meeting. June 25, 2011.
  30. Atluri P, Ullery BW, MacArthur JW, Murthy A, Hiesinger W, O’Hara ML, Jessup M, Acker MA,  Rame JE, Woo YJ. Left ventricular assist device implantation is an effective therapy for decreasing pulmonary hypertension and reducing heart transplant allograft right ventricular strain. Heart Failure Society of America, 15th Annual Scientific Meeting. September 18, 2011.
  31. Atluri P,  Goldstone AB, Fairman AS, Ullery BW, MacArthur JW, Shudo Y, Hiesinger W,  O’Hara ML, Fitzpatrick JR, Acker MA, Rame JE, Woo YJ. Quantitative pre-operative risk assessment of right ventricular failure during destination continuous flow left ventricular assist device implantation. International Society For Heart and Lung Transplantation 32nd Annual Meeting and Scientific Sessions. April 19, 2012.
  32. Atluri P, Dymond DJ, Woo YJ. Novel Technique for Implanting a HeartMate II Left ventricular assist device implantation in the presence of a hostile ventricle. International Society For Heart and Lung Transplantation 32nd Annual Meeting and Scientific Sessions. April 20, 2012.
  33. MacArthur JW, Trubelja A, Hiesinger W, Atluri P, Beason DP,  Woo YJ. Mathematically-engineered stromal cell-derived factor 1alpha stem cell cytokine analogue enhances mechanical properties of infarcted myocardium. Western Thoracic Surgical Association 38th Annual Meeting. June 30, 2012.
  34. Goldstone AB, Atluri P, Szeto WY, Trubelja A, Howard J, MacArthur JW,  Gorman RC, Gorman JH, Pochettino AP, Bavaria JE, Acker MA, Hargrove WC, Woo YJ. Minimally Invasive Versus Sternotomy Approaches To Isolated Mitral Valve Repair: A Propensity Matched Comparison.  Western Thoracic Surgical Association 38th Annual Meeting. June 30, 2012.
  35. Fairman AS, Atluri P, MacArthur JW, Yang E, Shudo Y, Hiesinger W,  Acker MA, Woo YJ. Continuous Flow Left Ventricular Assist Device Implant Significantly Improves Pulmonary Hypertension, Right Ventricular Contractility and Tricuspid Valve Competence. American College of Surgeons. October 4, 2012.
  36. Atluri P, Hsiao P, Trubelja A, MacArthur JW, Shudo Y, Yang E, Wang M, Fairman AS, Frederick JR, Woo YJ. Novel Tissue Engineered Angiogenic Construct To Enhance Endothelial Progenitor Cell Mediated Vasculogenic Activity And Normalize Myocardial Biomechanics. American Heart Association Scientific Sesions 2012. November 5, 2012.
  37. Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Hiesinger W, Howard JL,  Acker MA, Rame JE, Woo YJ. Preoperative Risk Stratification Of Right Ventricular Dysfunction In The Modern, Continuous Flow Left Ventricular Assist Device Era. Southern Thoracic Surgical Association Annual Meeting. November 10, 2012.
Chapters
  1. Atluri P, Woo YJ. The Cardiovascular System. The Surgical Review, Second Edition. Lippincott, William & Wilkins, Philadelphia, PA, 2005.
  2. Atluri P, Woo YJ. Cardiovascular Disease and Cardiovascular Surgery. The Surgical Review, 3rd Edition. Lippincott, William & Wilkins, Philadelphia, PA, 2009.
  3. Atluri P, Gorman RC, Gorman JH III, Acker MA. Ischemic Mitral Regurgitation. Cardiac Surgery in the Adult, 4th Edition. McGraw Hill 2011.
  4. Shafi B, Atluri P. Cardiac Surgery. The Intensive Care Unit Manual, 2nd Edition. Elsevier 2012.
  5. Atluri P, Acker MA. Ventricular Assist Devices. Current Therapy in Thoracic and Cardiovascular Surgery, 2nd Edition. Elsevier 2012.
Books
  1. Atluri P, Karakousis G, Porrett P, Kaiser L. editors, The Surgical Review, Second Edition. Lippincott Williams & Wilkins. Philadelphia, PA. 2005.
Invited Commentary
  1. Woo YJ, Atluri P. Reply to the Editor – “Angiogenesis and surgical or endovascular enhancement of non-coronary collateral circulation: a new research field”. J Thor Cardiovasc Surg. 2010; 139:1676-1677
  2. Atluri P. Editorial Commentary – “Myocardial transfection of adeno-hypoxia inducible factor-1a, a novel strategy to potentiate vasculogenesis in ischemic

Dr. Pavan Atluri

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine